FDRS variables predict Alzheimer's disease, dementia in heart failure, atrial fibrillation patients

03 Mar 2023
FDRS variables predict Alzheimer's disease, dementia in heart failure, atrial fibrillation patients

Variables from the Framingham Heart Study Dementia Risk Score (FDRS) are predictive of Alzheimer’s disease (AD) and AD-related dementias (ADRD) in patients with heart failure (HF) or atrial fibrillation (AF), a study has shown.

“The addition of comorbidities and risk factors only modestly improved prediction, indicating that the FDRS variables are appropriate to predict AD/ADRD in patients with HF and AF,” the authors said.

In this study, the authors identified residents aged ≥50 years from seven southeastern Minnesota counties in the US with a first diagnosis of HF or AF between 1 January 2013 and 31 December 2017. They excluded patients with AD/ADRD before or within 6 months after index AF or HF and those who died within 6 months following index.

Models were created for both cohorts to predict AD/ADRD after index, including variables in the FDRS. Comorbidities and risk factors were also added to the models. Finally, the authors calculated c-statistics using fivefold cross-validation for all models.

Of the 3,052 HF patients (mean age, 75 years, 53 percent male), 626 developed AD/ADRD, while 736 out of 4,107 AF patients (mean age 74 years, 57 percent male) developed AD/ADRD. In the HF cohort, the FDRS variables predicted AD/ADRD (c-statistic, 0.69). The addition of comorbidities and risk factors to the model slightly improved the c-statistic to 0.70.

Likewise, the FDRS variables predicted AD/ADRD in the AF cohort (c-statistic, 0.73), and the addition of comorbidities and risk factors slightly improved the c-statistic to 0.75.

“The FDRS was developed in a general population of older persons,” the authors said.

Am J Med 2023;136:302-307